(Q39318073)

11 September 2017

IL6 protects MN9D cells and midbrain dopaminergic neurons from MPP+-induced neurodegeneration (English)

1 reference

11 September 2017

1 reference

1 reference

Björn Spittau

1

1 reference

11 September 2017

Xiaolai Zhou

series ordinal

2

1 reference

11 September 2017

Ming Ming

series ordinal

3

1 reference

11 September 2017

Kerstin Krieglstein

series ordinal

4

1 reference

11 September 2017

8 July 2012

1 reference

11 September 2017

NeuroMolecular Medicine

1 reference

11 September 2017

14

1 reference

11 September 2017

4

1 reference

11 September 2017

317-327

1 reference

https://scigraph.springernature.com/pub.10.1007/s12017-012-8189-7

11 September 2017

0 references

cites work

The neuropoietic cytokine family in development, plasticity, disease and injury

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

1-methyl-4-phenyl-pyridinium ion (MPP+) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Effects of IL-6 secreted from astrocytes on the survival of dopaminergic neurons in lipopolysaccharide-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Interleukin-6 protects PC12 cells from 4-hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Possible role of interleukin-6 in PC12 cell death induced by MPP+ and tetrahydroisoquinoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Expression of CXCL10 in cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Serum levels of interleukin-6 are elevated in patients with Parkinson's disease and correlate with physical performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8189-7

Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice

21 January 2018

1 reference

12 December 2020

Heavy metal intensification of DAB-based HRP reaction product

1 reference

12 December 2020

The pathology of Parkinson's disease

1 reference

12 December 2020

Interleukin-1β Enhances Survival and Interleukin-6 Protects against MPP+ Neurotoxicity in Cultures of Fetal Rat Dopaminergic Neurons

1 reference

12 December 2020

TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity

1 reference

12 December 2020

cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease

1 reference

12 December 2020

Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures

1 reference

12 December 2020

Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines.

1 reference

12 December 2020

10.1007/S12017-012-8189-7

Identifiers

DOI

1 reference

11 September 2017

1 reference